Overview

Nexalin Therapy for the Treatment of Depressive Symptoms

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The primary objectives of this Phase II study are to demonstrate the safety of Nexalin Therapy and to investigate the efficacy of Nexalin Therapy.
Phase:
Phase 2
Details
Lead Sponsor:
Kalaco Scientific, Inc.
Treatments:
Antidepressive Agents
Citalopram
Dexetimide